Grant✓ Small businesses may apply
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
National Institutes of Health
Award ceiling
$350,000
- Opportunity #
- RFA-NS-25-023
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.846, 93.121, 93.213, 93.273, 93.847, 93.865, 93.393, 93.866, 93.853, 93.867
- Status
- posted
- Posted
- Sep 18, 2024
- Closes
- Jan 15, 2027
- Funding instrument
- Grant
- Category
- Education, Food and Nutrition, Health, Income Security and Social Services
- Cost sharing required
- No
Who can apply
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •For profit organizations other than small businesses
- •Special district governments
- •Native American tribal governments (Federally recognized)
- •State governments
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •Public and State controlled institutions of higher education
- •Independent school districts
- •Small businesses
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •City or township governments
- •Public housing authorities/Indian housing authorities
- •Private institutions of higher education
- •County governments
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Synopsis
This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal is to encourage initial translational efforts that will support a drug discovery program and advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program. The scope will therefore be focused on development of assays to support a distinct testing funnel, screening efforts to identify hits, and initial characterization of hits and potential therapeutic agents (including small molecules, biologics, and natural products).
Contact
National Institutes of Health · grantsinfo@nih.gov